Long-term outcome of lobar ablation versus completion thyroidectomy in differentiated thyroid cancer

Nuclear Medicine Communications

Volumn 32, Issue 1, 2011, Pages 52-58

  Santra, Amburanjan ^a   Bal, Susan ^a   Mahargan, Sagar ^a   Bal, Chandrasekhar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

completion thyroidectomy; differentiated thyroid cancer; hemithyroidectomy; lobar ablation; long term outcome

Indexed keywords

RADIOACTIVE IODINE;

ABLATION THERAPY; ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; RADIATION DOSE; RECURRENCE RISK; REOPERATION; RETROSPECTIVE STUDY; THYROID CANCER; THYROIDECTOMY; TREATMENT OUTCOME;

ABLATION TECHNIQUES; ADULT; CELL DIFFERENTIATION; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; RECURRENCE; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650307068     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328340e74c     Document Type: Article

References (30)

1. Pacini F, Elisei R, Capezzone M, Miccoli P, Molinaro E, Basolo F, et al. Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low-and high risk patients. Thyroid 2001; 11:877-881.
2. Kim ES, Kim TY, Koh JM, Kim YI, Hong SJ, Kim WB, et al. Completion thyroidectomy in patients with thyroid cancerwho initially underwent unilateral operation. Clin Endocrinol 2004; 61:145-148.
3. Pasieka JL, Thompson NW, McLeod MK, Burney RE, Macha M. The incidence of bilateral well-differentiated thyroid cancer found at completion thyroidectomy. World J Surg 1992; 16:711-717.
4. Eroglu A, Berberoglu U, Buruk F, Yildirim E. Completion thyroidectomy for differentiated thyroid carcinoma. J Surg Oncol 1995; 59:261-267
5. Reeves TS, Delbridge L, Brady P, Crummer P, Smyth C. Secondary thyroidectomy: a twenty year experience. World J Surg 1988; 12:449-453.
6. Menegaux F,Turpin G, Dahman M, Leenhardt L, Chadarevian R, Aurengo A, et al. Secondary thyroidectomy in patients with prior thyroid surgery for benign disease: a study of 203 cases. Surgery 1999; 126:479-483.
7. Miccoli P, Antonelli A, Spinelli C, Ferdeghini M, Fallahi P, Baschieri L Completion total thyroidectomy in children with thyroid cancer secondary to the Chernobyl accident. Arch Surg 1998; 133:89-93.
8. Levin KE, Clark AH, Duh QY, Demeure M, Siperstein AE, Clark OH. Reoperative thyroid surgery. Surgery 1992; 111:604-609.
9. Lefevre JH, Tresallet C, Leenhardt L, Jublanc C, Chigot JP, Menegaux F. Reoperative surgery for thyroid disease. Langenbecks Arch Surg 2007; 392:685-691.
10. Chao T, Jeng L, Lin J, Chen M. Completion thyroidectomy for differentiated thyroid carcinoma. Otolaryngol Head Neck Surg 1998; 118:896-899.
11. Wilson DB, Staren ED, Prinz RA. Thyroid reoperations: indications and risks. Am Surg 1998; 64:674-687.
12. Wax MK, Briant TDR. Completion thyroidectomy in the management of well-differentiated thyroid carcinoma. Otolaryngol Head Neck Surg 1992; 107:63-68.
13. Seiler CA, Glaser C, Wagner HE. Thyroid gland surgery in an endemic region. World J Surg 1996; 20:593-597.
14. Kupferman ME, Mandel SJ, DiDonato L, Wolf P, Weber RS. Safety of completion thyroidectomy following unilateral lobectomy for well-differentiated thyroid cancer. Laryngoscope 2002; 112:1209-1212.
15. Pezzullo L, Delrio P, Losito NS, Caraco C, Mozzillo N. Post-operative complications after completion thyroidectomy for differentiated thyroid cancer. Eur J Surg Oncol 1997; 23:215-218.
16. Scheumann GF, Seeliger H, Musholt TJ, Gimm O, Wegener G, Dralle H, et al. Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg 1996; 162:677-684.
17. Erdem E, Gülçelik MA, Kuru B, Alagöl H. Comparison of completion thyroidectomy and primary surgery for differentiated thyroid carcinoma. EurJ Surg Oncol 2003; 29:747-749.
18. Rafferty MA, Goldstein DP, Rotstein L, Asa SL, Panzarella T, Gullane P, et al. Completion thyroidectomy versus total thyroidectomy: is there a difference in complication rates? An analysis of 350 patients. J Am Coll Surg 2007; 205:602-607.
19. Randolph GW, Daniels GH. Radioactive iodine lobe ablation as an alternative to completion thyroidectomy for follicular carcinoma of the thyroid. Thyroid 2002; 12:989-996.
20. Bal CS, Kumar A, Pant GS. Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer. Nucl Med Commun 2003; 24:203-208.
21. Bal C, Padhy AK, Jana S, Pant GS, Basu AK. Prospective randomized clinical trial to evaluate the optimal dose of I-131 for remnant ablation in patients with differentiated thyroid carcinoma. Cancer 1996; 77:2574-2580.
22. Bal CS, Kumar A, Pant GS. Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients. J Clin Endocrinol Metab 2004; 89:1666-1673.
23. Links TP, van Tol KM, Jager PL, Plukker JT, Piers DA, Boezen HM, et al. Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis. Endocr Relat Cancer 2005; 12:273-280.
24. Bal CS, Kumar A, Chandra P, Dwivedi SN, Pant GS. A prospective clinical trial to assess the efficacy of radioiodine ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer undergoing sub-total thyroidectomy. Acta Oncol 2006; 45:1067-1072.
25. Lin JD, ChaoTC, Huang MJ, Weng HF,Tzen KY. Use of radioactive iodine for thyroid remnant ablation in well differentiated thyroid carcinoma to replace thyroid reoperation. Am J Clin Oncol1998; 21:77-81.
26. Hoyes KP, Owens SE, Millns MM, Allan E. Differentiated thyroid cancer: radioiodine following lobectomy: a clinical feasibility study. Nucl Med Commun 2004; 25:245-251.
27. Lablanc G, Tabah R, Liberman M, Sampalis J, Younan R, How J. Large remnant I-131 ablation as an alternative to completion/total thyroidectomy in the treatment of well-differentiated thyroid cancer. Surgery 2004; 136:1275-1280.
28. Pacini F, Castagna MG, Brilli L, Pentheroudakis G; ESMO Guidelines Working Group. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 (Suppl 5):v214-v219.
29. Shah JP Exploiting biology in selecting treatment for differentiated cancer of the thyroid gland. Eur Arch Otorhinolaryngol 2008; 265:1155-1160.
30. Barney BM, Hitchcock YJ, Sharma P, Shrieve DC, Tward JD. Overall and cause-specific survival for patients undergoing lobectomy, near-total, ortotal thyroidectomy for differentiated thyroid cancer. Head Neck 2010. doi: 10.1002/hed.21504. [Epub ahead of print]